World

Regeneron’s COVID-19 treatment gets emergency approval by FDA



The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.

The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.

The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.

Regeneron’s drug is a combination of two monoclonal antibodies. A similar drug developed by Eli Lilly & Co. gained FDA emergency clearance earlier this month.

However the Regeneron treatment may not be immediately widely available: the company has said it will have just 80,000 doses by the end of November.

Related posts

$100K raised for namesake of Arlo Guthrie’s ‘Alice’s Restaurant’

honynews12

Tyler Perry presents free Thanksgiving food to thousands in Atlanta

honynews12

Los Angeles orders more restrictions as COVID-19 surges

honynews12

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More